EVEROLIMUS SWANPOND INVESTMENTS 5 MG COMPRIMIDOS EFG
EVEROLIMUS SWANPOND INVESTMENTS 5 MG COMPRIMIDOS EFG
Pending
Register Number
85346
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Aug 10, 2020
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number85346
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
EVEROLIMUSActive
Quantity: 5 mg
Name: EVEROLIMUS
ATC CLASSIFICATION (3)
L01E
L01EG
L01EG02